4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-030688
Director bought 44,648 shares at an average $55.35 ($2,471,251)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamond David Director | 2020-05-15 | Purchase | +1,263 | $46.30 | $58,478 | 1,654,599 | I |
| Lamond David Director | 2020-05-15 | Purchase | +985 | $48.37 | $47,640 | 1,655,584 | I |
| Lamond David Director | 2020-05-15 | Purchase | +1,600 | $48.96 | $78,333 | 1,657,184 | I |
| Lamond David Director | 2020-05-15 | Purchase | +1,000 | $50.71 | $50,707 | 1,658,184 | I |
| Lamond David Director | 2020-05-15 | Purchase | +500 | $52.20 | $26,101 | 1,658,684 | I |
| Lamond David Director | 2020-05-15 | Purchase | +100 | $53.10 | $5,310 | 1,658,784 | I |
| Lamond David Director | 2020-05-19 | Purchase | +400 | $54.09 | $21,636 | 1,659,184 | I |
| Lamond David Director | 2020-05-19 | Purchase | +5,906 | $55.42 | $327,309 | 1,665,090 | I |
| Lamond David Director | 2020-05-19 | Purchase | +32,894 | $56.42 | $1,855,738 | 1,697,984 | I |
| Open-market purchases · 44,648 sh · avg $55.35 · $2,471,251 | |||||||
Loading xslF345X03/doc4.xml…